A Li-Wan-Po

Summary

Country: UK

Publications

  1. ncbi How high should total pain-relief score be to obviate the need for analgesic remedication in acute pain? Estimation using signal detection theory and individual-patient meta-analysis
    A Li Wan Po
    Centre for Evidence Based Pharmacotherapy, Nottingham, UK
    J Clin Pharm Ther 31:161-5. 2006
  2. ncbi Dose-response of minor analgesics in acute pain
    Alain Li Wan Po
    National Genetics Education and Development Centre, Birmingham and Centre for Evidence-Based Pharmacotherapy, Nottingham, UK
    Br J Clin Pharmacol 63:268-70. 2007
  3. ncbi Personalised medicine: who is an Asian?
    Alain Li Wan Po
    National Genetics Education and Development Centre, Birmingham, UK
    Lancet 369:1770-1. 2007
  4. ncbi Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example
    Alain Li-Wan-Po
    National Genetics Education and Development Centre, c o Birmingham Women s Hospital, Edgbaston, UK
    Eur J Clin Pharmacol 66:369-74. 2010
  5. ncbi Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
    Alain Li-Wan-Po
    National Genetics Education and Development Centre, c o Birmingham Women s Hospital, UK
    Br J Clin Pharmacol 69:222-30. 2010
  6. ncbi Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine
    Alain Li-Wan-Po
    National Genetics Education and Development Centre, Morris House, c o Birmingham Women s Hospital, Edgbaston, Birmingham, United Kingdom
    Br J Clin Pharmacol 72:6-17. 2011
  7. ncbi Barking up the wrong genome--we are not alone
    A Li-Wan-Po
    National Genetics Education and Development Centre, c o Birmingham s Women s Hospital, Edgbaston, Birmingham, UK
    J Clin Pharm Ther 36:125-7. 2011

Collaborators

Detail Information

Publications7

  1. ncbi How high should total pain-relief score be to obviate the need for analgesic remedication in acute pain? Estimation using signal detection theory and individual-patient meta-analysis
    A Li Wan Po
    Centre for Evidence Based Pharmacotherapy, Nottingham, UK
    J Clin Pharm Ther 31:161-5. 2006
    ..A pain relief score 50% of the maximum is often used as a clinically meaningful outcome in meta-analyses of analgesic trials. This arbitrary value requires validation...
  2. ncbi Dose-response of minor analgesics in acute pain
    Alain Li Wan Po
    National Genetics Education and Development Centre, Birmingham and Centre for Evidence-Based Pharmacotherapy, Nottingham, UK
    Br J Clin Pharmacol 63:268-70. 2007
  3. ncbi Personalised medicine: who is an Asian?
    Alain Li Wan Po
    National Genetics Education and Development Centre, Birmingham, UK
    Lancet 369:1770-1. 2007
  4. ncbi Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example
    Alain Li-Wan-Po
    National Genetics Education and Development Centre, c o Birmingham Women s Hospital, Edgbaston, UK
    Eur J Clin Pharmacol 66:369-74. 2010
    ..To illustrate the interface of pharmacogenetics and therapeutic drug monitoring and to estimate target blood level for imatinib in the treatment of chronic myelogenous leukemia..
  5. ncbi Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
    Alain Li-Wan-Po
    National Genetics Education and Development Centre, c o Birmingham Women s Hospital, UK
    Br J Clin Pharmacol 69:222-30. 2010
    ..Investigators disagree about the phenotype to be assigned to the two CYP2C19*17 genotypes. The aim of this study was to provide a critical summary, helpful to prescribers...
  6. ncbi Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine
    Alain Li-Wan-Po
    National Genetics Education and Development Centre, Morris House, c o Birmingham Women s Hospital, Edgbaston, Birmingham, United Kingdom
    Br J Clin Pharmacol 72:6-17. 2011
    ..If on-going well designed trials confirm their efficacy, the outlook for Marfan syndrome patients would be improved considerably...
  7. ncbi Barking up the wrong genome--we are not alone
    A Li-Wan-Po
    National Genetics Education and Development Centre, c o Birmingham s Women s Hospital, Edgbaston, Birmingham, UK
    J Clin Pharm Ther 36:125-7. 2011
    ..Here, we wish to draw attention to how our microbiome may contribute to variability in drug effects...